Baxter International (BAX) Stock Forecast & Price Target

$36.90

-1.06 (-2.79%)

(As of 10/1/2024 ET)

Baxter International - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 11 Analyst Ratings

Sell
1

Hold
8

Buy
2

Based on 11 Wall Street analysts who have issued ratings for Baxter International in the last 12 months, the stock has a consensus rating of "Hold." Out of the 11 analysts, 1 has given a sell rating, 8 have given a hold rating, and 2 have given a buy rating for BAX.

Consensus Price Target

$42.00
13.81% Upside

According to the 11 analysts' twelve-month price targets for Baxter International, the average price target is $42.00. The highest price target for BAX is $54.00, while the lowest price target for BAX is $30.00. The average price target represents a forecasted upside of 13.81% from the current price of $36.91.

Get the Latest News and Ratings for BAX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Baxter International and its competitors.

BAX Analyst Ratings Over Time

Type	Current Forecast 10/3/23 to 10/2/24	1 Month Ago 9/3/23 to 9/2/24	3 Months Ago 7/5/23 to 7/4/24	1 Year Ago 10/3/22 to 10/3/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	3 Buy rating(s)	4 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$42.00	$41.73	$44.46	$50.80
Forecasted Upside	13.81% Upside	9.98% Upside	34.08% Upside	38.04% Upside
Consensus Rating	Hold	Hold	Hold	Hold

Shedding light on a dark secret (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,

BAX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Baxter International Stock vs. The Competition

Type	Baxter International	Medical Companies	S&P 500
Consensus Rating Score	2.09	2.78	2.50
Consensus Rating	Hold	Moderate Buy	Hold
Predicted Upside	13.81% Upside	807.92% Upside	6.86% Upside
News Sentiment Rating	Neutral News See Recent BAX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
10/1/2024	Citigroup 3 of 5 stars	Boost Target	Neutral ➝ Neutral	$38.00 ➝ $40.00	+8.40%
8/8/2024	The Goldman Sachs Group 2 of 5 stars	Boost Target	Neutral ➝ Neutral	$36.00 ➝ $40.00	+8.20%
8/7/2024	JPMorgan Chase & Co. 3 of 5 stars	Lower Target	Neutral ➝ Neutral	$44.00 ➝ $42.00	+13.61%
8/7/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$44.00 ➝ $40.00	+6.84%
7/15/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Equal Weight ➝ Underweight	$39.00 ➝ $30.00	-15.06%
7/2/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$46.00 ➝ $45.00	+36.12%
Get the Latest News and Ratings for BAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.
5/10/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$40.00	+11.27%
3/5/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$42.00 ➝ $45.00	+2.93%
2/12/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$52.00 ➝ $54.00	+35.71%
2/6/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$40.00 ➝ $36.00	-8.28%
10/24/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Hold ➝ Hold	$35.00 ➝ $50.00	+52.72%
7/31/2023	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight	$53.00 ➝ $51.00	+8.49%
7/12/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$54.00 ➝ $56.00	+21.66%
5/30/2023	888 Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Assumes
2/10/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform	$70.00 ➝ $45.00	+12.11%
1/5/2023	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
10/12/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold	$62.00	+11.09%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 02:34 AM ET.

Should I Buy Baxter International Stock? BAX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, September 24, 2024. Please send any questions or comments about these Baxter International pros and cons to contact@marketbeat.com.

Baxter International
Bull Case

Here are some ways that investors could benefit from investing in Baxter International Inc.:

Baxter International Inc. stock price has been showing an upward trend, currently trading at $39.22, indicating potential growth.
Recent quarterly earnings report exceeded analysts' expectations, with a net margin of 16.51% and a return on equity of 18.06%, showcasing strong financial performance.
Increasing stake by institutional investors like Hexagon Capital Partners LLC and BNP Paribas Financial Markets indicates confidence in the company's future prospects.
Baxter International Inc. has a dividend yield of 3.06%, providing investors with a steady income stream.
The company's diverse portfolio of healthcare products positions it well to capitalize on the growing healthcare industry.

Baxter International
Bear Case

Investors should be bearish about investing in Baxter International Inc. for these reasons:

Several research firms have downgraded Baxter International Inc.'s rating, indicating potential concerns about future performance.
Target price reductions by analysts like Morgan Stanley and JPMorgan Chase & Co. suggest a cautious outlook on the stock.
Goldman Sachs Group's neutral rating and Evercore ISI's price target adjustment may signal uncertainty in the company's growth trajectory.
Market consensus rating of "Hold" and a consensus target price of $41.73 imply a lack of strong buy signals from analysts.
Debt-to-equity ratio of 1.35 and a beta of 0.59 may pose risks in a volatile market environment, impacting investor confidence.

BAX Forecast - Frequently Asked Questions

: According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Baxter International is $42.00, with a high forecast of $54.00 and a low forecast of $30.00.
: 11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There is currently 1 sell rating, 8 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" BAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAX, but not buy additional shares or sell existing shares.
: According to analysts, Baxter International's stock has a predicted upside of 13.81% based on their 12-month stock forecasts.
: Over the previous 90 days, Baxter International's stock had 1 downgrade by analysts.
: Baxter International has been rated by research analysts at Citigroup, JPMorgan Chase & Co., Morgan Stanley, The Goldman Sachs Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Baxter International less than other "medical" companies. The consensus rating for Baxter International is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BAX compares to other companies.